These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36370451)

  • 1. Following the Indian Immigrant: adoption of westernization results in a western gut microbiome and an increased risk of inflammatory bowel diseases.
    D'Aloisio LD; Shetty V; Ballal M; Gibson DL
    FEMS Microbiol Ecol; 2022 Nov; 98(12):. PubMed ID: 36370451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
    Kaplan GG; Bernstein CN; Coward S; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S6-S16. PubMed ID: 31294381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Bowel Disease Environmental Risk Factors: Diet and Gut Microbiota.
    Altajar S; Moss A
    Curr Gastroenterol Rep; 2020 Oct; 22(12):57. PubMed ID: 33044636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urbanization and the gut microbiota in health and inflammatory bowel disease.
    Zuo T; Kamm MA; Colombel JF; Ng SC
    Nat Rev Gastroenterol Hepatol; 2018 Jul; 15(7):440-452. PubMed ID: 29670252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut Microbiota in Inflammatory Bowel Disease.
    Qiu P; Ishimoto T; Fu L; Zhang J; Zhang Z; Liu Y
    Front Cell Infect Microbiol; 2022; 12():733992. PubMed ID: 35273921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and inflammatory bowel disease.
    Chen L; Wang J
    WIREs Mech Dis; 2022 Mar; 14(2):e1540. PubMed ID: 35266651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview.
    M'Koma AE
    Gastrointest Disord (Basel); 2019 Mar; 1(1):75-105. PubMed ID: 37577036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leaky Gut in IBD: Intestinal Barrier-Gut Microbiota Interaction.
    Yu S; Sun Y; Shao X; Zhou Y; Yu Y; Kuai X; Zhou C
    J Microbiol Biotechnol; 2022 Jul; 32(7):825-834. PubMed ID: 35791076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges.
    Yan J; Wang L; Gu Y; Hou H; Liu T; Ding Y; Cao H
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
    Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
    Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods.
    Bakir-Gungor B; Hac─▒lar H; Jabeer A; Nalbantoglu OU; Aran O; Yousef M
    PeerJ; 2022; 10():e13205. PubMed ID: 35497193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome.
    Larmonier CB; Shehab KW; Ghishan FK; Kiela PR
    Biomed Res Int; 2015; 2015():504638. PubMed ID: 26583115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
    Healey GR; Celiberto LS; Lee SM; Jacobson K
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
    Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
    Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.